Enteropathy-associated T-cell lymphoma: Epidemiology, clinical features, and current treatment strategies

Current Hematologic Malignancy Reports

Volumn 6, Issue 4, 2011, Pages 231-240

  Sieniawski, Michal K ^a   Lennard, Anne L ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

ASCT; Autologous stem cell transplantation; Clinical features; Conservative treatment with surgery and anthracycline based chemotherapy; EATL; Enteropathy associated T cell lymphoma; Epidemiology; HDCT; High dose chemotherapy; Survival

Indexed keywords

ANTHRACYCLINE; CD103 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; VINCRISTINE;

AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PATIENT; DISEASE CLASSIFICATION; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; GENOTYPE; HUMAN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREVALENCE; PROGRESSION FREE SURVIVAL; REVIEW; WORLD HEALTH ORGANIZATION;

ANTINEOPLASTIC AGENTS; CELIAC DISEASE; COMBINED MODALITY THERAPY; ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA; HUMANS; STEM CELL TRANSPLANTATION;

EID: 81355148871     PISSN: 15588211     EISSN: 1558822X     Source Type: Journal    
DOI: 10.1007/s11899-011-0097-7     Document Type: Review

References (50)

1. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008.
2. J Gale PD Simmonds GM Mead JW Sweetenham DH Wright 2000 Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center J Clin Oncol. 18 795 803 10673521 1:STN:280:DC%2BD3c7jvFCrtg%3D%3D (Pubitemid 30106610)
3. P Domizio RA Owen NA Shepherd IC Talbot AJ Norton 1993 Primary lymphoma of the small intestine. A clinicopathological study of 119 cases Am J Surg Pathol. 17 429 442 8470758 10.1097/00000478-199305000-00001 1:STN:280: DyaK3s3ivVWmtw%3D%3D (Pubitemid 23121773)
4. PG Isaacson MQ Du 2005 Gastrointestinal lymphoma: where morphology meets molecular biology J Pathol. 205 255 274 15643667 10.1002/path.1703 1:CAS:528:DC%2BD2MXhsFOgsrg%3D (Pubitemid 40227996)
5. C Catassi E Fabiani G Corrao, et al. 2002 Risk of non-Hodgkin lymphoma in celiac disease JAMA. 287 1413 11903028 10.1001/jama.287.11.1413
6. A Diamanti F Colistro A Calce, et al. 2006 Clinical value of immunoglobulin A antitransglutaminase assay in the diagnosis of celiac disease Pediatrics. 118 e1696 e1700 17074840 10.1542/peds.2006-0604 (Pubitemid 46397543)
7. PH Green C Cellier 2007 Celiac disease N Engl J Med. 357 1731 1743 17960014 10.1056/NEJMra071600 1:CAS:528:DC%2BD2sXht1alsLjN (Pubitemid 350005154)
8. C Cellier E Delabesse C Helmer, et al. 2000 Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French coeliac disease study group Lancet. 356 203 208 10963198 10.1016/S0140-6736(00)02481-8 1:STN:280:DC%2BD3cvjtVemtw%3D%3D (Pubitemid 30446975)
9. PG Isaacson 1985 Malignant histiocytosis of the intestine J Pathol. 147 3 227 228 4067739 10.1002/path.1711470311 1:STN:280:DyaL28%2Fmt1Skuw%3D%3D
10. PD Howdle PK Jalal GK Holmes RS Houlston 2003 Primary small-bowel malignancy in the UK and its association with coeliac disease QJM. 96 345 353 12702783 10.1093/qjmed/hcg058 1:STN:280:DC%2BD3s7otl2msw%3D%3D (Pubitemid 36592706)
11. TT Salmi P Collin IR Korponay-Szabo, et al. 2006 Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits Gut. 55 1746 1753 16571636 10.1136/gut.2005.071514 1:CAS:528:DC%2BD2sXkvFKqtw%3D%3D (Pubitemid 44893572)
12. RJ Deleeuw A Zettl E Klinker, et al. 2007 Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes Gastroenterology. 132 1902 1911 17484883 10.1053/j.gastro.2007.03.036 1:CAS:528:DC%2BD2sXmsVymsLs%3D (Pubitemid 46677947)
13. C Dube A Rostom R Sy, et al. 2005 The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review Gastroenterology. 128 S57 S67 15825128 10.1053/j.gastro.2005.02.014 (Pubitemid 40460823)
14. A Fasano I Berti T Gerarduzzi, et al. 2003 Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study Arch Intern Med. 163 286 292 12578508 10.1001/archinte.163.3.286 (Pubitemid 36183856)
15. WH Verbeek JM Van De Water A Al-Toma JJ Oudejans CJ Mulder VM Coupe 2008 Incidence of enteropathy-associated T-cell lymphoma: a nation-wide study of a population-based registry in The Netherlands Scand J Gastroenterol. 43 1322 1328 18618372 10.1080/00365520802240222
16. S Daum C Cellier CJ Mulder 2005 Refractory coeliac disease Best Pract Res Clin Gastroenterol. 19 413 424 15925846 10.1016/j.bpg.2005.02.001 (Pubitemid 40753762)
17. A Al-Toma WH Verbeek M Hadithi BM von Blomberg CJ Mulder 2007 Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience Gut. 56 1373 1378 17470479 10.1136/gut.2006.114512 1:STN:280:DC%2BD2srjvFCmtw%3D%3D (Pubitemid 47517830)
18. A Chott W Haedicke I Mosberger, et al. 1998 Most CD56+ intestinal lymphomas are CD8 + CD5-T-cell lymphomas of monomorphic small to medium size histology Am J Pathol. 153 1483 1490 9811340 10.1016/S0002-9440(10)65736-7 1:STN:280:DyaK1M%2FislCkuw%3D%3D (Pubitemid 28509905)
19. A Chott M Vesely I Simonitsch I Mosberger H Hanak 1999 Classification of intestinal T-cell neoplasms and their differential diagnosis Am J Clin Pathol. 111 S68 S74 9894471 1:STN:280:DyaK1M7htFynsA%3D%3D
20. J Spencer N Cerf-Bensussan A Jarry, et al. 1988 Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes Am J Pathol. 132 1 5 3260750 1:STN:280:DyaL1c3nvFKktw%3D%3D
21. DH Wright 1997 Enteropathy associated T cell lymphoma Cancer Surv. 30 249 261 9547996 1:STN:280:DyaK1c3gvFaitQ%3D%3D (Pubitemid 27371546)
22. A Murray EC Cuevas DB Jones DH Wright 1995 Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma Am J Pathol. 146 509 519 7856760 1:STN:280:DyaK2M7mtVWnuw%3D%3D
23. WM Howell ST Leung DB Jones, et al. 1995 HLA-DRB, -DQA, and -DQB polymorphism in celiac disease and enteropathy-associated T-cell lymphoma. Common features and additional risk factors for malignancy Hum Immunol. 43 29 37 7558926 10.1016/0198-8859(94)00130-I 1:STN:280:DyaK28%2FltlGitw%3D%3D
24. A Zettl G Ott A Makulik, et al. 2002 Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma Am J Pathol. 161 1635 1645 12414511 10.1016/S0002-9440(10)64441-0 1:CAS:528:DC%2BD38XptV2gt7o%3D (Pubitemid 35265523)
25. M Sieniawski N Angamuthu K Boyd, et al. 2010 Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation Blood 115 3664 3670 20197551 10.1182/blood-2009-07-231324 1:CAS:528:DC%2BC3cXms1egurg%3D The Scotland and Newcastle Lymphoma Group (SNLG) performed a detailed, population-based evaluation of patients with EATL registered with the group between 1994 and 1998. Data obtained included patient demographics, details on baseline evaluations, treatment, and patient outcomes. They also presented the results of novel first-line treatment with ifosfamide, etoposide, and epirubicin with intermediate-dose methotrexate followed by ASCT
26. • D'Amore F, Lauritzen G, Jantunen E, et al. Dose-dense induction followed by autologous stem cell transplant (ASCT) leads to sustained remissions in a large fraction of patients with previously untreated peripheral T-cell lymphomas (PTCLs) - overall and subtype specific results of a phase II study from the Nordic Lymphoma Group. 14th Congress of the EHA. 2009. This is an interim analysis of a big, multicenter, prospective study on dose-dense induction with CHOEP-14 followed by ASCT in patients with PTCL. Among the 160 patients included were 21 patients with EATL.
27. J Delabie H Holte JM Vose, et al. 2011 Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project Blood 118 148 155 21566094 10.1182/blood-2011-02-335216 1:CAS:528:DC%2BC3MXptlSntLw%3D The International T-cell Lymphoma Project (ITLP) studied a cohort of 62 EATL patients among 1,153 patients with PTCL from 22 centers worldwide, diagnosed between 1990 and 2002. Clinical correlation and survival analyses were performed
28. EL Berman NP Zauber RR Rickert TC Diss PG Isaacson 1998 Enteropathy-associated T cell lymphoma with brain involvement J Clin Gastroenterol 26 337 341 9649024 10.1097/00004836-199806000-00026 1:STN:280:DyaK1czhtFemug%3D%3D (Pubitemid 28272517)
29. AN Tutt M Brada SA Sampson 1997 Enteropathy associated T cell lymphoma presenting as an isolated CNS lymphoma three years after diagnosis of coeliac disease: T cell receptor polymerase chain reaction studies failed to show the original enteropathy to be a clonal disorder Gut. 40 801 9245937 10.1136/gut.40.6.801 1:STN:280:DyaK2szovVOjtg%3D%3D
30. S Daum R Ullrich W Heise, et al. 2003 Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German study group on intestinal non-Hodgkin's Lymphoma J Clin Oncol. 21 2740 2746 12860953 10.1200/JCO.2003.06.026 (Pubitemid 46606320)
31. A Al-Toma OJ Visser HM van Roessel, et al. 2007 Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells Blood. 109 2243 2249 17068146 10.1182/blood-2006-08-042820 1:CAS:528: DC%2BD2sXjtFCjsrg%3D (Pubitemid 46348229)
32. OA O'Connor S Horwitz P Hamlin, et al. 2009 Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies J Clin Oncol. 27 4357 4364 19652067 10.1200/JCO.2008.20.8470
33. R Piekarz J Wright R Frye SL Allen M Craig L Geskin 2008 Results of a phase 2 NCI multicentre study of romidepsin in patients with relapsed peripheral T-cell lymphoma (PTCL) Blood (ASH Annual Meeting Abstracts) 112 1567
34. GS Dueck N Chua A Prasad D Stewart D White R van der Jagt 2009 Activity of lenalidomide in a phase II trial for T-cell lymphoma: Report on the first 24 cases J Clin Oncol (ASCO Meeting Abstracts) 27 8524
35. RR Furman L Gore F Ravandi D Hoelzer 2006 Forodesine IV (Bcx 1777) is clinically active in relapsed/refractory T-cell leukemia: Results of a phase II study (interim report) Blood (ASH Annual Meeting Abstracts) 108 1851
36. PL Zinzani M Magagnoli M Bendandi, et al. 1998 Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients Ann Oncol. 9 1351 1353 9932168 10.1023/A:1008409601731 1:STN:280:DyaK1M7jtV2lsg%3D%3D (Pubitemid 29045577)
37. S Sallah JY Wan NP Nguyen 2001 Treatment of refractory T-cell malignancies using gemcitabine Br J Haematol. 113 185 187 11328299 10.1046/j.1365-2141.2001.02743.x 1:CAS:528:DC%2BD3MXkt1SjsL0%3D (Pubitemid 32423320)
38. P Reimer T Rudiger E Geissinger, et al. 2009 Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study J Clin Oncol 27 106 113 19029417 10.1200/JCO.2008.17.4870 1:CAS:528:DC%2BD1MXhs1Gnsbo%3D This multicenter, prospective trial assessed the role of ASCT in consolidation in patients with PTCL in first remission after the standard treatment with CHOP
39. N Mounier C Gisselbrecht J Briere, et al. 2004 All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) Ann Oncol. 15 1790 1797 15550584 10.1093/annonc/mdh471 1:STN:280: DC%2BD2crotVGitQ%3D%3D (Pubitemid 40012245)
40. M Okuda J Nomura H Tateno J Kameoka T Sasaki 2002 CD56 positive intestinal T-cell lymphoma: treatment with high dose chemotherapy and autologous peripheral blood stem cell transplantation Intern Med. 41 734 737 12322803 10.2169/internalmedicine.41.734
41. C Rongey I Micallef T Smyrk J Murray 2006 Successful treatment of enteropathy-associated T cell lymphoma with autologous stem cell transplant Dig Dis Sci. 51 1082 1086 16865575 10.1007/s10620-006-8013-z (Pubitemid 44127059)
42. A Al-Toma WH Verbeek OJ Visser, et al. 2007 Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma Dig Liver Dis. 39 634 641 17531561 10.1016/j.dld.2007.03.009 1:STN:280:DC%2BD2szls12muw%3D%3D (Pubitemid 46888208)
43. M Nickelsen M Ziepert S Zeynalova, et al. 2009 High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) Ann Oncol. 20 1977 1984 19570965 10.1093/annonc/mdp211 1:STN:280:DC%2BD1MjntFOjtA%3D%3D
44. MS Goerres JW Meijer PJ Wahab, et al. 2003 Azathioprine and prednisone combination therapy in refractory coeliac disease Aliment Pharmacol Ther. 18 487 494 12950421 10.1046/j.1365-2036.2003.01687.x 1:CAS:528:DC%2BD3sXot1Oqt7w%3D (Pubitemid 37152289)
45. EF Bernstein PF Whitington 1988 Successful treatment of atypical sprue in an infant with cyclosporine Gastroenterology. 95 199 204 3371614 1:STN:280:DyaL1c3isF2itg%3D%3D
46. PJ Wahab JB Crusius JW Meijer JJ Uil CJ Mulder 2000 Cyclosporin in the treatment of adults with refractory coeliac disease-an open pilot study Aliment Pharmacol Ther. 14 767 774 10848661 10.1046/j.1365-2036.2000.00718.x 1:CAS:528:DC%2BD3cXltFSltLo%3D (Pubitemid 30352744)
47. CJ Mulder PJ Wahab JW Meijer E Metselaar 2001 A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease Eur J Gastroenterol Hepatol. 13 1183 1188 11711774 10.1097/00042737-200110000-00010 1:CAS:528:DC%2BD3MXosFCgs74%3D (Pubitemid 33015884)
48. A Al-Toma MS Goerres JW Meijer, et al. 2006 Cladribine therapy in refractory celiac disease with aberrant T cells Clin Gastroenterol Hepatol 4 1322 1327 16979946 10.1016/j.cgh.2006.07.007 1:CAS:528:DC%2BD28Xhtlartr%2FM quiz 1300 (Pubitemid 44716738)
49. M Mallant M Hadithi AB Al-Toma, et al. 2007 Abdominal computed tomography in refractory coeliac disease and enteropathy associated T-cell lymphoma World J Gastroenterol. 13 1696 1700 17461472 (Pubitemid 46711340)
50. M Hadithi M Mallant J Oudejans JH van Waesberghe CJ Mulder EF Comans 2006 18 F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease J Nucl Med. 47 1622 1627 17015897 (Pubitemid 47545027)